Forex
World
Market
Business
Cryptocurrency
Commodities
MAP
Publish for free
Business
financetom
/
Business
/
--Tesla Chief Information Officer Nagesh Saldi is Leaving, Bloomberg Reports
News
World
Market
Environment
Technology
Personal Finance
Politics
Retail
Business
Economy
Cryptocurrency
Forex
Stocks Market
Commodities
--Tesla Chief Information Officer Nagesh Saldi is Leaving, Bloomberg Reports
Oct 3, 2024 10:08 AM
12:39 PM EDT, 10/03/2024 (MT Newswires) --
Price: 242.54, Change: -6.48, Percent Change: -2.60
Previous page:
Canterbury Park Q3 revenue drops as casino activity weakens
Next page:
Pliant Therapeutics Q3 net loss narrows to $26.3 mln
Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Release time ⇩
Release time ⇧
Like count ⇩
Show More Comments
Related Articles >
Canterbury Park Q3 revenue drops as casino activity weakens
Nov 6, 2025
Overview * Canterbury Park ( CPHC ) Q3 revenue falls 5% yr/yr, impacted by reduced casino revenues * Net income for Q3 declines significantly, impacted by prior year land transfer gain * Adjusted EBITDA for Q3 decreases, reflecting lower casino revenue and stable expenses Outlook * Company did not provide specific financial guidance for future quarters or full year Result...
Pliant Therapeutics Q3 net loss narrows to $26.3 mln
Nov 6, 2025
Overview * Pliant Q3 net loss narrows to $26.3 mln, driven by BEACON-IPF discontinuation * Company completed voluntary prepayment of Oxford Finance loan Outlook * BEACON-IPF close out activities to be completed in Q4 2025 Result Drivers * R&D EXPENSES - Decrease primarily due to discontinuation of BEACON-IPF trial * ADMINISTRATIVE COSTS - Decline due to strategic workforce restructuring Key...
Trisura Group Q3 Operating Earnings Meets Forecast
Nov 6, 2025
04:53 PM EST, 11/06/2025 (MT Newswires) -- Trisura Group ( TRRSF ) Thursday after-trade reported higher third-quarter operating earnings that met forecasts. The specialty insurer said operating net income rose 3.6% to $34.4 million, or $0.71 per share, from $33.2 million, or $0.68, in the prior-year period. The improvement was due to profitable underwriting and growth in net investment income....
Protagonist Therapeutics Q3 net loss widens to $39.3 mln
Nov 6, 2025
Overview * Protagonist Therapeutics ( PTGX ) reports Q3 net loss of $39.3 mln, increased R&D expenses noted * Cash reserves of $678.8 mln expected to sustain operations through 2028 * NDA for icotrokinra submitted to FDA, rusfertide gets breakthrough designation Outlook * Protagonist expects rusfertide NDA filing by end of 2025 * Company anticipates PN-477sc clinical study initiation by...
About
Terms and Conditions
Privacy policy
Cookie Settings
Contact Us
Services
Login
register
financetom
Market
Personal Finance
Business
Economy
Cryptocurrency
MAP
Links
zpostcode
Recruit
weather
mreligion
Yellowpages
sport
constellation
shopping
name
game
directory
literature
Word
tour
furnish
Lottery
tftnews
lyrics
News
digital
car
dir
Edu
Finance
Copyright 2023-2026 -
www.financetom.com
All Rights Reserved
News
World
Market
Environment
Technology
Personal Finance
Politics
Retail
Business
Economy
Cryptocurrency
MAP